Securisyn Medical
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
N/A | $25.0k | Angel | |
N/A | $50.0k | Seed | |
N/A | $3.6m | Early VC | |
$2.5m | Seed | ||
N/A | $3.1m | Early VC | |
* | N/A | Grant | |
* | $250k | Grant | |
Total Funding | €8.7m |
Recent News about Securisyn Medical
EditSecurisyn Medical specializes in developing advanced airway stabilization systems designed to enhance patient safety and reduce healthcare costs associated with unplanned extubation. Operating in the medical technology sector, Securisyn serves hospitals, clinics, and healthcare providers who manage ventilated patients. The company's flagship product, the SolidAIRity system, aims to prevent accidental or unplanned removal of endotracheal tubes, thereby reducing complications such as ventilator-associated pneumonia and extended hospital stays. Securisyn's business model focuses on selling these medical devices directly to healthcare institutions and through strategic partnerships. Revenue is generated through product sales, service contracts, and recurring maintenance fees. The company has received multiple accolades, including FDA 510(k) clearance and contracts with the U.S. Air Force, and is a participant in the Mayo Clinic and Arizona State University MedTech Accelerator.
Keywords: airway stabilization, unplanned extubation, healthcare costs, ventilated patients, medical devices, patient safety, SolidAIRity system, FDA clearance, MedTech, healthcare innovation.